These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-specific immunostimulation in bronchogenic cancer. Israel L. Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224 [No Abstract] [Full Text] [Related]
3. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung]. Fujisawa T. Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513 [Abstract] [Full Text] [Related]
4. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis. Hadźiev S, Mandulova P, Kavaklieva-Dimitrova J, Penev K, Spassova M, Madźarova S. Neoplasma; 1982 Jan; 29(1):93-110. PubMed ID: 6280082 [Abstract] [Full Text] [Related]
5. [Immunotherapy of lung cancer]. Jassem J, Jassem E. Pol Tyg Lek; 1982 Jun 14; 37(17):497-9. PubMed ID: 6292882 [No Abstract] [Full Text] [Related]
6. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer. Wright PW, Hill LD, Peterson AV, Pinkham R, Johnson L, Ivey T, Bernstein I, Bagley C, Anderson R. Cancer Treat Rep; 1978 Nov 14; 62(11):1671-5. PubMed ID: 215304 [Abstract] [Full Text] [Related]
7. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy. Warren SE, Crispen RG, Nika B. Am Surg; 1978 Jul 14; 44(7):428-31. PubMed ID: 686527 [Abstract] [Full Text] [Related]
8. [Immunotherapy of carcinoma of the lung]. Sega E, Mineo TC, Rea SR, Sega FM, Ricci C. Recenti Prog Med; 1978 Mar 14; 64(3):293-309. PubMed ID: 351751 [No Abstract] [Full Text] [Related]
11. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin. Yasumoto K, Manabe H, Yanagawa E, Nagano N, Ueda H, Hirota N, Ohta M, Nomoto K, Azuma I, Yamamura Y. Cancer Res; 1979 Aug 14; 39(8):3262-7. PubMed ID: 222448 [Abstract] [Full Text] [Related]
12. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin. Grant SC, Kris MG, Houghton AN, Chapman PB. Clin Cancer Res; 1999 Jun 14; 5(6):1319-23. PubMed ID: 10389914 [Abstract] [Full Text] [Related]
13. [Monoclonal antibodies to lung cancer antigens (a review of the literature)]. Tkacheva GA. Med Radiol (Mosk); 1989 May 14; 34(5):62-75. PubMed ID: 2542715 [No Abstract] [Full Text] [Related]
14. Immune status in lung cancer: effects of BCG immunotherapy. Gross NJ, Eddie-Quartey AC. Am Rev Respir Dis; 1976 Apr 14; 113(4):457-64. PubMed ID: 178255 [Abstract] [Full Text] [Related]
15. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment]. Janicka G, Chyczewska E, Przylipiak M, Kowal E. Pol Tyg Lek; 1985 Aug 26; 40(34):963-6. PubMed ID: 2999734 [No Abstract] [Full Text] [Related]
17. Adjuvant systemic therapy of lung cancer. Muggia FM, McGuire WP. Cancer Clin Trials; 1978 Aug 26; 1(3):235-41. PubMed ID: 229981 [Abstract] [Full Text] [Related]
18. [Reevaluation of immunopotentiation therapy for cancer]. Toyoshima K. Gan To Kagaku Ryoho; 2000 Jun 26; 27(6):817-23. PubMed ID: 10897207 [Abstract] [Full Text] [Related]
19. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung. Lachmann PJ, Grant RM, Freedman LS, Sikora K, Bleehen NM. Br J Cancer; 1985 Mar 26; 51(3):415-7. PubMed ID: 3882114 [No Abstract] [Full Text] [Related]
20. [Immunotherapy in bronchial carcinoma]. Havemann K. Onkologie; 1980 Jun 26; 3(3):120-6. PubMed ID: 6258119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]